182 related articles for article (PubMed ID: 34563875)
21. Annual stroke incidence in Nigerian children with sickle cell disease and elevated TCD velocities treated with hydroxyurea.
Lagunju I; Brown BJ; Oyinlade AO; Asinobi A; Ibeh J; Esione A; Sodeinde OO
Pediatr Blood Cancer; 2019 Mar; 66(3):e27252. PubMed ID: 29797633
[TBL] [Abstract][Full Text] [Related]
22. Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.
Bernaudin F; Verlhac S; Peffault de Latour R; Dalle JH; Brousse V; Petras E; Thuret I; Paillard C; Neven B; Galambrun C; Divialle-Doumdo L; Pondarré C; Guitton C; Missud F; Runel C; Jubert C; Elana G; Ducros-Miralles E; Drain E; Taïeb O; Arnaud C; Kamdem A; Malric A; Elmaleh-Bergès M; Vasile M; Leveillé E; Socié G; Chevret S;
JAMA; 2019 Jan; 321(3):266-276. PubMed ID: 30667500
[TBL] [Abstract][Full Text] [Related]
23. Transcranial Doppler screening in Nigerian children with sickle cell disease: A 10-year longitudinal study on the SPPIBA cohort.
Lagunju IA; Labaeka A; Ibeh JN; Orimadegun AE; Brown BJ; Sodeinde OO
Pediatr Blood Cancer; 2021 Apr; 68(4):e28906. PubMed ID: 33522690
[TBL] [Abstract][Full Text] [Related]
24. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
[TBL] [Abstract][Full Text] [Related]
25. Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.
Hankins JS; McCarville MB; Rankine-Mullings A; Reid ME; Lobo CL; Moura PG; Ali S; Soares DP; Aldred K; Jay DW; Aygun B; Bennett J; Kang G; Goldsmith JC; Smeltzer MP; Boyett JM; Ware RE
Am J Hematol; 2015 Dec; 90(12):1099-105. PubMed ID: 26414435
[TBL] [Abstract][Full Text] [Related]
26. Transcranial Doppler ultrasonography in children with sickle cell anemia: Clinical and laboratory correlates for elevated blood flow velocities.
Lagunju I; Sodeinde O; Brown B; Akinbami F; Adedokun B
J Clin Ultrasound; 2014 Feb; 42(2):89-95. PubMed ID: 24166013
[TBL] [Abstract][Full Text] [Related]
27. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
[TBL] [Abstract][Full Text] [Related]
28. Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework.
Ghafuri DL; Abdullahi SU; Dambatta AH; Galadanci J; Tabari MA; Bello-Manga H; Idris N; Inuwa H; Tijjani A; Suleiman AA; Jibir BW; Gambo S; Gambo AI; Khalifa Y; Haliru L; Abdulrasheed S; Zakari MA; Greene BC; Trevathan E; Jordan LC; Aliyu MH; Baumann AA; DeBaun MR
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e56-e61. PubMed ID: 34001783
[TBL] [Abstract][Full Text] [Related]
29. Transcranial Doppler Ultrasonography Imaging Studies in Children with Sickle Cell Anaemia in a Tertiary Hospital, Abuja, Nigeria.
Mohammed-Nafi'u R; Oniyangi O; Akano AO; Aikhionbare HA; Okon EJ
West Afr J Med; 2021 May; 38(5):460-464. PubMed ID: 34051718
[TBL] [Abstract][Full Text] [Related]
30. How I manage sickle cell patients with high transcranial doppler results.
Brewin J; Kaya B; Chakravorty S
Br J Haematol; 2017 Nov; 179(3):377-388. PubMed ID: 28771666
[TBL] [Abstract][Full Text] [Related]
31. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study.
Kanter J; Phillips S; Schlenz AM; Mueller M; Dooley M; Sirline L; Nickel R; Brown RC; Hilliard L; Melvin CL; Adams RJ
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1062-e1068. PubMed ID: 33625093
[TBL] [Abstract][Full Text] [Related]
32. What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
Estepp JH; Cong Z; Agodoa I; Kang G; Ding J; McCarville MB; Hankins JS; Wang WC
Br J Haematol; 2021 Jul; 194(2):463-468. PubMed ID: 34131902
[TBL] [Abstract][Full Text] [Related]
33. EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.
Rankine-Mullings AE; Little CR; Reid ME; Soares DP; Taylor-Bryan C; Knight-Madden JM; Stuber SE; Badaloo AV; Aldred K; Wisdom-Phipps ME; Latham T; Ware RE
JMIR Res Protoc; 2016 Sep; 5(3):e185. PubMed ID: 27619954
[TBL] [Abstract][Full Text] [Related]
34. Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial.
Pavlakis SG; Rees RC; Huang X; Brown RC; Casella JF; Iyer RV; Kalpatthi R; Luden J; Miller ST; Rogers ZR; Thornburg CD; Wang WC; Adams RJ;
Pediatr Blood Cancer; 2010 Feb; 54(2):256-9. PubMed ID: 19813252
[TBL] [Abstract][Full Text] [Related]
35. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
36. Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic review.
Mazzucco S; Diomedi M; Qureshi A; Sainati L; Padayachee ST
Int J Stroke; 2017 Aug; 12(6):580-588. PubMed ID: 28440126
[TBL] [Abstract][Full Text] [Related]
37. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
Rankine-Mullings A; Reid M; Soares D; Taylor-Bryan C; Wisdom-Phipps M; Aldred K; Latham T; Schultz WH; Knight-Madden J; Badaloo A; Lane A; Adams RJ; Ware RE
Br J Haematol; 2021 Nov; 195(4):612-620. PubMed ID: 34291449
[TBL] [Abstract][Full Text] [Related]
38. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study.
Adams RJ; Brambilla DJ; Granger S; Gallagher D; Vichinsky E; Abboud MR; Pegelow CH; Woods G; Rohde EM; Nichols FT; Jones A; Luden JP; Bowman L; Hagner S; Morales KH; Roach ES;
Blood; 2004 May; 103(10):3689-94. PubMed ID: 14751925
[TBL] [Abstract][Full Text] [Related]
39. Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial.
Abdullahi SU; Sunusi S; Abba MS; Sani S; Inuwa HA; Gambo S; Gambo A; Musa B; Covert Greene BV; Kassim AA; Rodeghier M; Hussaini N; Ciobanu M; Aliyu MH; Jordan LC; DeBaun MR
Blood; 2023 Feb; 141(8):825-834. PubMed ID: 36322937
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia.
McCarville MB; Goodin GS; Fortner G; Li CS; Smeltzer MP; Adams R; Wang W
Pediatr Blood Cancer; 2008 Apr; 50(4):818-21. PubMed ID: 18085672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
